欧美日韩一二区,日韩欧美国产一区二区粉嫩,九九热最新免费在线观看,亚洲精品第一页

咨詢熱線

15000266580

當前位置:首頁 >產(chǎn)品中心>細胞庫>人腫瘤細胞、癌細胞>CRL-1420MIA PaCa-2 人胰腺癌細胞 (STR)

MIA PaCa-2 人胰腺癌細胞 (STR)

簡要描述:CRL-1420 MIA PaCa-2 人胰腺癌細胞
ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞;細胞庫管理規(guī)范,提供的細胞株背景清楚,提供參考文獻和培養(yǎng)條件!

  • 產(chǎn)品型號:CRL-1420
  • 廠商性質(zhì):生產(chǎn)廠家
  • 更新時間:2025-04-27
  • 訪  問  量:3427

產(chǎn)品分類

Product Category

詳細介紹

細胞名稱人胰腺導管癌細胞; MIA PaCa-2 (STR)
別名MIA-PaCa-2; MIA-PACA-2; MIA-Pa-Ca-2; MIA Paca2; MIA PaCa2; MiaPaCa-2; MIAPACA-2; MiaPaca.2; MiaPaCa2; Miapaca2; MIAPaCa2; MIAPACA2; Mia PACA 2; MIAPaCa-2; PaCa2; MiaPaCa
貨號XF0752
規(guī)格1×10?cells/T25培養(yǎng)瓶
形態(tài)特征?上皮細胞樣
生長特性半貼壁生長
培養(yǎng)基DMEM+10%FBS+2.5%HS     【MIA PaCa-2培養(yǎng)基有售,請聯(lián)系客服
凍存條件無血清細胞凍存液
培養(yǎng)條件氣相:空氣,95%;CO2,5%
溫度:37℃
傳代方法1:2傳代;
特征特性DMEM-H: Dulbecco's Modified Eagle's Medium (DME H-21 4.5g/Liter Glucose)   10%FBS


CRL-1420  MIA PaCa-2 人胰腺癌細胞 的介紹

ATCC® Number: CRL-1420™ Price: $279.00

Designations: MIA PaCa-2

Depositors: A Yunis

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: adherent, single cells and loosely attached clusters

Organism: Homo sapiens (human)

Morphology: attached epithelial with floating rounded cells


Source: Organ: pancreas

Disease: carcinoma

Cellular Products: human colony stimulating factor, subclass I (CSF-I); plasminogen activator

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory per

mits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Isolation: Isolation date: 1975

DNA Profile (STR): Amelogenin: X

CSF1PO: 10

D13S317: 12,13

D16S539: 10,13

D5S818: 12,13

D7S820: 12,13

THO1: 9,10

TPOX: 9

vWA: 15

Cytogenetic Analysis: This is a hypotriploid human cell line. The modal chromosome number is 61. Sixteen to 20 marker chromosomes are commonly found in a cell. A few normal chromosomes are absent.

Isoenzymes: G6PD, B

Age: 65 years

Gender: male

Ethnicity: Caucasian

Comments: The MIA PaCa-2 cell line was established by A. Yunis, et al. in 1975 from tumor tissue of the pancreas obtained from a 65-year-old Caucasian male. [58034]

The established cell line reportedly has a doubling time of about 40 hours and a colony-forming efficiency in soft agar of approximay 19%. [58034]

Hybridomas have been made against the CSF-I produced by this line ATCC HB-8207

References: 1057: Wu M, et al. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 16: 1908-1913, 1977. PubMed: 15590

22291: Fountzilas G, et al. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2). J. Natl. Cancer Inst. 76: 37-43, 1986. PubMed: 3455740

49623: Robertson JF, et al. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer. Int. J. Cancer 63: 69-75, 1995. PubMed: 7558455


CRL-1420  MIA PaCa-2 人胰腺癌細胞























產(chǎn)品咨詢

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結(jié)果(填寫阿拉伯數(shù)字),如:三加四=7
聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術支持:化工儀器網(wǎng)    管理登陸
6080YYY午夜理论AA片| 公愆憩止痒48小说| 和上司在办公室疯狂的做| 久久婷婷香蕉热狠狠综合| 永久免费观看国产裸体美女| 无套内谢少妇毛片免费看看| 少妇厨房愉情理伦bd在线观看| 性熟妇videos另类hd| 吃奶揉捏奶头高潮视频在线观看| 湿润手指揉捏调教H女友| 国产96在线 | 亚洲| 欧美人与善交大片免费看| 曰本女人与公拘交酡| yy111111少妇无码理论片| 色情A片成人免费看| 17岁日本高清免费观看完整版 | 中国无码人妻丰满熟妇啪啪软件 | 国产成人无码av片在线观看不卡| 人妻借种太粗进不去| 久久久人人人婷婷色东京热| 娇妻在客厅被朋友玩得呻吟| 羞羞视频| 天天爽夜夜爽人人爽一区二区| 51成人午夜福利性色AV| 老翁的大肉蟒进进出出| 中国老熟女重囗味HDXX| 色99蜜臀av无码波多野结衣 | 欲求不満な人妻は毎晩隣人に| 免费国产黄网站在线观看动图| 久久精品女人18国产毛片蜜桃| 高H纯肉大尺度调教PLAY| 他强把手指伸进我的下面| 在车里掀起乳罩啃咬奶头| 无遮无挡爽爽免费毛片| 被C到喷水嗯H| 最美情侣中文字幕电影| 多毛BGMBGMBGM胖觉觉| 欧美在线 | 亚洲| 办公室双腿打开揉弄高潮淑芬| 欧美精产国品一二三产品区别| 七旬老人为满足需求|